GSK
797 hedge funds and large institutions have $12.7B invested in GSK in 2021 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 275 increasing their positions, 259 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
797
Holders Change
+24
Holders Change %
+3.1%
% of All Funds
13.91%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.24%
New
95
Increased
275
Reduced
259
Closed
64
Calls
$241M
Puts
$173M
Net Calls
+$67.2M
Net Calls Change
+$31.1M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$239M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$111M |
| 3 |
CA
Capitolis Advisors
New York
|
+$60.7M |
| 4 |
Barclays
London,
United Kingdom
|
+$46.1M |
| 5 |
Goldman Sachs
New York
|
+$36.3M |
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$307M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$77.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$56.6M |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$38.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$38.3M |